Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt
NCT ID: NCT04339322
Last Updated: 2020-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2020-05-01
2020-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asymptomatic COVID-19 Infection Among Healthcare Workers
NCT04354792
Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
NCT04353336
COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience
NCT04554979
Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
NCT04847661
Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
NCT04351919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be followed until complications, improvement, transfer to another hospital or death and their outcome will be described.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Covid-19
Patients with clinical presentation and confirmed as Covid-19 according to the definition of Egyptian Ministry of Health
Follow up
Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow up
Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haidi Karam
Lecturer of Tropical Medicine and Gastroenterology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-19 in Egypt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.